The possible reduction of YBX1 cytoplasmic availability inhibits proliferation of myeloid differentiation-inducing apoptosis and decreases the expression of cyclin D1 and cyclin E1 associated with pancreatic ductal adenocarcinoma cell growth. This evidence concerns the gene CCNE1 and pancreatic ductal adenocarcinoma.